<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d273" origId="Eszopiclone"><sentence id="DrugDDI.d273.s0" origId="s0" text="CNS-Active Drugs Ethanol An additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol 0.70 g/kg for up to 4 hours after ethanol administration."><entity id="DrugDDI.d273.s0.e0" origId="s0.p0" charOffset="0-16" type="drug" text="cns-active drugs"/><entity id="DrugDDI.d273.s0.e1" origId="s0.p5" charOffset="105-116" type="drug" text="eszopiclone"/><entity id="DrugDDI.d273.s0.e2" origId="s0.p7" charOffset="121-128" type="drug" text="ethanol"/><entity id="DrugDDI.d273.s0.e3" origId="s0.p11" charOffset="163-170" type="drug" text="ethanol"/><pair id="DrugDDI.d273.s0.p0" e1="DrugDDI.d273.s0.e0" e2="DrugDDI.d273.s0.e1" interaction="false"/><pair id="DrugDDI.d273.s0.p1" e1="DrugDDI.d273.s0.e0" e2="DrugDDI.d273.s0.e2" interaction="false"/><pair id="DrugDDI.d273.s0.p2" e1="DrugDDI.d273.s0.e0" e2="DrugDDI.d273.s0.e3" interaction="false"/><pair id="DrugDDI.d273.s0.p3" e1="DrugDDI.d273.s0.e1" e2="DrugDDI.d273.s0.e2" interaction="true"/><pair id="DrugDDI.d273.s0.p4" e1="DrugDDI.d273.s0.e1" e2="DrugDDI.d273.s0.e3" interaction="false"/><pair id="DrugDDI.d273.s0.p5" e1="DrugDDI.d273.s0.e2" e2="DrugDDI.d273.s0.e3" interaction="false"/></sentence><sentence id="DrugDDI.d273.s1" origId="s1" text="Paroxetine Coadministration of single doses of eszopiclone 3 mg and paroxetine 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction."><entity id="DrugDDI.d273.s1.e0" origId="s1.p12" charOffset="0-10" type="drug" text="Paroxetine"/><entity id="DrugDDI.d273.s1.e1" origId="s1.p14" charOffset="47-63" type="drug" text="eszopiclone 3 mg"/><entity id="DrugDDI.d273.s1.e2" origId="s1.p16" charOffset="68-84" type="drug" text="paroxetine 20 mg"/><pair id="DrugDDI.d273.s1.p0" e1="DrugDDI.d273.s1.e0" e2="DrugDDI.d273.s1.e1" interaction="false"/><pair id="DrugDDI.d273.s1.p1" e1="DrugDDI.d273.s1.e0" e2="DrugDDI.d273.s1.e2" interaction="false"/><pair id="DrugDDI.d273.s1.p2" e1="DrugDDI.d273.s1.e1" e2="DrugDDI.d273.s1.e2" interaction="false"/></sentence><sentence id="DrugDDI.d273.s2" origId="s2" text="Lorazepam Coadministration of single doses of eszopiclone 3 mg and lorazepam 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug."><entity id="DrugDDI.d273.s2.e0" origId="s2.p22" charOffset="0-9" type="drug" text="Lorazepam"/><entity id="DrugDDI.d273.s2.e1" origId="s2.p24" charOffset="46-62" type="drug" text="eszopiclone 3 mg"/><entity id="DrugDDI.d273.s2.e2" origId="s2.p26" charOffset="67-81" type="drug" text="lorazepam 2 mg"/><entity id="DrugDDI.d273.s2.e3" origId="s2.p36" charOffset="177-181" type="drug" text="drug"/><pair id="DrugDDI.d273.s2.p0" e1="DrugDDI.d273.s2.e0" e2="DrugDDI.d273.s2.e1" interaction="false"/><pair id="DrugDDI.d273.s2.p1" e1="DrugDDI.d273.s2.e0" e2="DrugDDI.d273.s2.e2" interaction="false"/><pair id="DrugDDI.d273.s2.p2" e1="DrugDDI.d273.s2.e0" e2="DrugDDI.d273.s2.e3" interaction="false"/><pair id="DrugDDI.d273.s2.p3" e1="DrugDDI.d273.s2.e1" e2="DrugDDI.d273.s2.e2" interaction="false"/><pair id="DrugDDI.d273.s2.p4" e1="DrugDDI.d273.s2.e1" e2="DrugDDI.d273.s2.e3" interaction="false"/><pair id="DrugDDI.d273.s2.p5" e1="DrugDDI.d273.s2.e2" e2="DrugDDI.d273.s2.e3" interaction="false"/></sentence><sentence id="DrugDDI.d273.s3" origId="s3" text="Olanzapine Coadministration of eszopiclone 3 mg and olanzapine 10 mg produced a decrease in DSST scores."><entity id="DrugDDI.d273.s3.e0" origId="s3.p37" charOffset="0-10" type="drug" text="Olanzapine"/><entity id="DrugDDI.d273.s3.e1" origId="s3.p38" charOffset="31-47" type="drug" text="eszopiclone 3 mg"/><entity id="DrugDDI.d273.s3.e2" origId="s3.p40" charOffset="52-68" type="drug" text="olanzapine 10 mg"/><pair id="DrugDDI.d273.s3.p0" e1="DrugDDI.d273.s3.e0" e2="DrugDDI.d273.s3.e1" interaction="false"/><pair id="DrugDDI.d273.s3.p1" e1="DrugDDI.d273.s3.e0" e2="DrugDDI.d273.s3.e2" interaction="false"/><pair id="DrugDDI.d273.s3.p2" e1="DrugDDI.d273.s3.e1" e2="DrugDDI.d273.s3.e2" interaction="true"/></sentence><sentence id="DrugDDI.d273.s4" origId="s4" text="The interaction was pharmacodynamic;"/><sentence id="DrugDDI.d273.s5" origId="s5" text="there was no alteration in the pharmacokinetics of either drug."><entity id="DrugDDI.d273.s5.e0" origId="s5.p54" charOffset="58-62" type="drug" text="drug"/></sentence><sentence id="DrugDDI.d273.s6" origId="s6" text="Drugs That Inhibit CYP3A4 (Ketoconazole) CYP3A4 is a major metabolic pathway for elimination of eszopiclone."><entity id="DrugDDI.d273.s6.e0" origId="s6.p55" charOffset="0-5" type="drug" text="Drugs"/><entity id="DrugDDI.d273.s6.e1" origId="s6.p58" charOffset="19-25" type="drug" text="CYP3A4"/><entity id="DrugDDI.d273.s6.e2" origId="s6.p60" charOffset="27-39" type="drug" text="Ketoconazole"/><entity id="DrugDDI.d273.s6.e3" origId="s6.p62" charOffset="41-47" type="drug" text="CYP3A4"/><entity id="DrugDDI.d273.s6.e4" origId="s6.p66" charOffset="96-107" type="drug" text="eszopiclone"/><pair id="DrugDDI.d273.s6.p0" e1="DrugDDI.d273.s6.e0" e2="DrugDDI.d273.s6.e1" interaction="false"/><pair id="DrugDDI.d273.s6.p1" e1="DrugDDI.d273.s6.e0" e2="DrugDDI.d273.s6.e2" interaction="false"/><pair id="DrugDDI.d273.s6.p2" e1="DrugDDI.d273.s6.e0" e2="DrugDDI.d273.s6.e3" interaction="false"/><pair id="DrugDDI.d273.s6.p3" e1="DrugDDI.d273.s6.e0" e2="DrugDDI.d273.s6.e4" interaction="true"/><pair id="DrugDDI.d273.s6.p4" e1="DrugDDI.d273.s6.e1" e2="DrugDDI.d273.s6.e2" interaction="false"/><pair id="DrugDDI.d273.s6.p5" e1="DrugDDI.d273.s6.e1" e2="DrugDDI.d273.s6.e3" interaction="false"/><pair id="DrugDDI.d273.s6.p6" e1="DrugDDI.d273.s6.e1" e2="DrugDDI.d273.s6.e4" interaction="false"/><pair id="DrugDDI.d273.s6.p7" e1="DrugDDI.d273.s6.e2" e2="DrugDDI.d273.s6.e3" interaction="false"/><pair id="DrugDDI.d273.s6.p8" e1="DrugDDI.d273.s6.e2" e2="DrugDDI.d273.s6.e4" interaction="false"/><pair id="DrugDDI.d273.s6.p9" e1="DrugDDI.d273.s6.e3" e2="DrugDDI.d273.s6.e4" interaction="false"/></sentence><sentence id="DrugDDI.d273.s7" origId="s7" text="The AUC of eszopiclone was increased 2.2-fold by coadministration of ketoconazole, a potent inhibitor of CYP3A4, 400 mg daily for 5 days."><entity id="DrugDDI.d273.s7.e0" origId="s7.p68" charOffset="11-22" type="drug" text="eszopiclone"/><entity id="DrugDDI.d273.s7.e1" origId="s7.p73" charOffset="69-81" type="drug" text="ketoconazole"/><entity id="DrugDDI.d273.s7.e2" origId="s7.p75" charOffset="105-111" type="drug" text="CYP3A4"/><pair id="DrugDDI.d273.s7.p0" e1="DrugDDI.d273.s7.e0" e2="DrugDDI.d273.s7.e1" interaction="true"/><pair id="DrugDDI.d273.s7.p1" e1="DrugDDI.d273.s7.e0" e2="DrugDDI.d273.s7.e2" interaction="false"/><pair id="DrugDDI.d273.s7.p2" e1="DrugDDI.d273.s7.e1" e2="DrugDDI.d273.s7.e2" interaction="false"/></sentence><sentence id="DrugDDI.d273.s8" origId="s8" text="Cmax and t1/2 were increased 1.4-fold and 1.3-fold, respectively."><entity id="DrugDDI.d273.s8.e0" origId="s8.p80" charOffset="9-11" type="drug" text="t1"/></sentence><sentence id="DrugDDI.d273.s9" origId="s9" text="Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly."><entity id="DrugDDI.d273.s9.e0" origId="s9.p89" charOffset="27-33" type="drug" text="CYP3A4"/><entity id="DrugDDI.d273.s9.e1" origId="s9.p92" charOffset="41-53" type="drug" text="itraconazole"/><entity id="DrugDDI.d273.s9.e2" origId="s9.p93" charOffset="55-69" type="drug" text="clarithromycin"/><entity id="DrugDDI.d273.s9.e3" origId="s9.p94" charOffset="71-81" type="drug" text="nefazodone"/><entity id="DrugDDI.d273.s9.e4" origId="s9.p95" charOffset="83-97" type="drug" text="troleandomycin"/><entity id="DrugDDI.d273.s9.e5" origId="s9.p96" charOffset="99-108" type="drug" text="ritonavir"/><entity id="DrugDDI.d273.s9.e6" origId="s9.p97" charOffset="110-120" type="drug" text="nelfinavir"/><pair id="DrugDDI.d273.s9.p0" e1="DrugDDI.d273.s9.e0" e2="DrugDDI.d273.s9.e1" interaction="false"/><pair id="DrugDDI.d273.s9.p1" e1="DrugDDI.d273.s9.e0" e2="DrugDDI.d273.s9.e2" interaction="false"/><pair id="DrugDDI.d273.s9.p2" e1="DrugDDI.d273.s9.e0" e2="DrugDDI.d273.s9.e3" interaction="false"/><pair id="DrugDDI.d273.s9.p3" e1="DrugDDI.d273.s9.e0" e2="DrugDDI.d273.s9.e4" interaction="false"/><pair id="DrugDDI.d273.s9.p4" e1="DrugDDI.d273.s9.e0" e2="DrugDDI.d273.s9.e5" interaction="false"/><pair id="DrugDDI.d273.s9.p5" e1="DrugDDI.d273.s9.e0" e2="DrugDDI.d273.s9.e6" interaction="false"/><pair id="DrugDDI.d273.s9.p6" e1="DrugDDI.d273.s9.e1" e2="DrugDDI.d273.s9.e2" interaction="false"/><pair id="DrugDDI.d273.s9.p7" e1="DrugDDI.d273.s9.e1" e2="DrugDDI.d273.s9.e3" interaction="false"/><pair id="DrugDDI.d273.s9.p8" e1="DrugDDI.d273.s9.e1" e2="DrugDDI.d273.s9.e4" interaction="false"/><pair id="DrugDDI.d273.s9.p9" e1="DrugDDI.d273.s9.e1" e2="DrugDDI.d273.s9.e5" interaction="false"/><pair id="DrugDDI.d273.s9.p10" e1="DrugDDI.d273.s9.e1" e2="DrugDDI.d273.s9.e6" interaction="false"/><pair id="DrugDDI.d273.s9.p11" e1="DrugDDI.d273.s9.e2" e2="DrugDDI.d273.s9.e3" interaction="false"/><pair id="DrugDDI.d273.s9.p12" e1="DrugDDI.d273.s9.e2" e2="DrugDDI.d273.s9.e4" interaction="false"/><pair id="DrugDDI.d273.s9.p13" e1="DrugDDI.d273.s9.e2" e2="DrugDDI.d273.s9.e5" interaction="false"/><pair id="DrugDDI.d273.s9.p14" e1="DrugDDI.d273.s9.e2" e2="DrugDDI.d273.s9.e6" interaction="false"/><pair id="DrugDDI.d273.s9.p15" e1="DrugDDI.d273.s9.e3" e2="DrugDDI.d273.s9.e4" interaction="false"/><pair id="DrugDDI.d273.s9.p16" e1="DrugDDI.d273.s9.e3" e2="DrugDDI.d273.s9.e5" interaction="false"/><pair id="DrugDDI.d273.s9.p17" e1="DrugDDI.d273.s9.e3" e2="DrugDDI.d273.s9.e6" interaction="false"/><pair id="DrugDDI.d273.s9.p18" e1="DrugDDI.d273.s9.e4" e2="DrugDDI.d273.s9.e5" interaction="false"/><pair id="DrugDDI.d273.s9.p19" e1="DrugDDI.d273.s9.e4" e2="DrugDDI.d273.s9.e6" interaction="false"/><pair id="DrugDDI.d273.s9.p20" e1="DrugDDI.d273.s9.e5" e2="DrugDDI.d273.s9.e6" interaction="false"/></sentence><sentence id="DrugDDI.d273.s10" origId="s10" text="Drugs That Induce CYP3A4 (Rifampicin) Racemic zopiclone exposure was decreased 80% by concomitant useof rifampicin, a potent inducer of CYP3A4."><entity id="DrugDDI.d273.s10.e0" origId="s10.p105" charOffset="0-5" type="drug" text="Drugs"/><entity id="DrugDDI.d273.s10.e1" origId="s10.p108" charOffset="18-24" type="drug" text="CYP3A4"/><entity id="DrugDDI.d273.s10.e2" origId="s10.p110" charOffset="26-36" type="drug" text="Rifampicin"/><entity id="DrugDDI.d273.s10.e3" origId="s10.p112" charOffset="46-55" type="drug" text="zopiclone"/><entity id="DrugDDI.d273.s10.e4" origId="s10.p116" charOffset="104-114" type="drug" text="rifampicin"/><entity id="DrugDDI.d273.s10.e5" origId="s10.p118" charOffset="136-142" type="drug" text="CYP3A4"/><pair id="DrugDDI.d273.s10.p0" e1="DrugDDI.d273.s10.e0" e2="DrugDDI.d273.s10.e1" interaction="false"/><pair id="DrugDDI.d273.s10.p1" e1="DrugDDI.d273.s10.e0" e2="DrugDDI.d273.s10.e2" interaction="false"/><pair id="DrugDDI.d273.s10.p2" e1="DrugDDI.d273.s10.e0" e2="DrugDDI.d273.s10.e3" interaction="false"/><pair id="DrugDDI.d273.s10.p3" e1="DrugDDI.d273.s10.e0" e2="DrugDDI.d273.s10.e4" interaction="false"/><pair id="DrugDDI.d273.s10.p4" e1="DrugDDI.d273.s10.e0" e2="DrugDDI.d273.s10.e5" interaction="false"/><pair id="DrugDDI.d273.s10.p5" e1="DrugDDI.d273.s10.e1" e2="DrugDDI.d273.s10.e2" interaction="false"/><pair id="DrugDDI.d273.s10.p6" e1="DrugDDI.d273.s10.e1" e2="DrugDDI.d273.s10.e3" interaction="false"/><pair id="DrugDDI.d273.s10.p7" e1="DrugDDI.d273.s10.e1" e2="DrugDDI.d273.s10.e4" interaction="false"/><pair id="DrugDDI.d273.s10.p8" e1="DrugDDI.d273.s10.e1" e2="DrugDDI.d273.s10.e5" interaction="false"/><pair id="DrugDDI.d273.s10.p9" e1="DrugDDI.d273.s10.e2" e2="DrugDDI.d273.s10.e3" interaction="true"/><pair id="DrugDDI.d273.s10.p10" e1="DrugDDI.d273.s10.e2" e2="DrugDDI.d273.s10.e4" interaction="false"/><pair id="DrugDDI.d273.s10.p11" e1="DrugDDI.d273.s10.e2" e2="DrugDDI.d273.s10.e5" interaction="false"/><pair id="DrugDDI.d273.s10.p12" e1="DrugDDI.d273.s10.e3" e2="DrugDDI.d273.s10.e4" interaction="false"/><pair id="DrugDDI.d273.s10.p13" e1="DrugDDI.d273.s10.e3" e2="DrugDDI.d273.s10.e5" interaction="false"/><pair id="DrugDDI.d273.s10.p14" e1="DrugDDI.d273.s10.e4" e2="DrugDDI.d273.s10.e5" interaction="false"/></sentence><sentence id="DrugDDI.d273.s11" origId="s11" text="A similar effect would be expected with eszopiclone."><entity id="DrugDDI.d273.s11.e0" origId="s11.p123" charOffset="40-51" type="drug" text="eszopiclone"/></sentence><sentence id="DrugDDI.d273.s12" origId="s12" text="Drugs Highly Bound To Plasma Protein Eszopiclone is not highly bound to plasma proteins (52-59% bound);"><entity id="DrugDDI.d273.s12.e0" origId="s12.p124" charOffset="0-5" type="drug" text="Drugs"/><entity id="DrugDDI.d273.s12.e1" origId="s12.p126" charOffset="22-36" type="drug" text="Plasma Protein"/><entity id="DrugDDI.d273.s12.e2" origId="s12.p130" charOffset="72-87" type="drug" text="plasma proteins"/><pair id="DrugDDI.d273.s12.p0" e1="DrugDDI.d273.s12.e0" e2="DrugDDI.d273.s12.e1" interaction="false"/><pair id="DrugDDI.d273.s12.p1" e1="DrugDDI.d273.s12.e0" e2="DrugDDI.d273.s12.e2" interaction="false"/><pair id="DrugDDI.d273.s12.p2" e1="DrugDDI.d273.s12.e1" e2="DrugDDI.d273.s12.e2" interaction="false"/></sentence><sentence id="DrugDDI.d273.s13" origId="s13" text="therefore, the disposition of eszopiclone is not expected to be sensitive to alterations in protein binding."><entity id="DrugDDI.d273.s13.e0" origId="s13.p137" charOffset="30-41" type="drug" text="eszopiclone"/></sentence><sentence id="DrugDDI.d273.s14" origId="s14" text="Administration of eszopiclone 3 mg to a patient taking another drug that is highly protein-bound would not be expected to cause an alteration in the free concentration of either drug."><entity id="DrugDDI.d273.s14.e0" origId="s14.p147" charOffset="18-34" type="drug" text="eszopiclone 3 mg"/><entity id="DrugDDI.d273.s14.e1" origId="s14.p150" charOffset="63-67" type="drug" text="drug"/><entity id="DrugDDI.d273.s14.e2" origId="s14.p153" charOffset="83-90" type="drug" text="protein"/><entity id="DrugDDI.d273.s14.e3" origId="s14.p165" charOffset="178-182" type="drug" text="drug"/><pair id="DrugDDI.d273.s14.p0" e1="DrugDDI.d273.s14.e0" e2="DrugDDI.d273.s14.e1" interaction="false"/><pair id="DrugDDI.d273.s14.p1" e1="DrugDDI.d273.s14.e0" e2="DrugDDI.d273.s14.e2" interaction="false"/><pair id="DrugDDI.d273.s14.p2" e1="DrugDDI.d273.s14.e0" e2="DrugDDI.d273.s14.e3" interaction="false"/><pair id="DrugDDI.d273.s14.p3" e1="DrugDDI.d273.s14.e1" e2="DrugDDI.d273.s14.e2" interaction="false"/><pair id="DrugDDI.d273.s14.p4" e1="DrugDDI.d273.s14.e1" e2="DrugDDI.d273.s14.e3" interaction="false"/><pair id="DrugDDI.d273.s14.p5" e1="DrugDDI.d273.s14.e2" e2="DrugDDI.d273.s14.e3" interaction="false"/></sentence><sentence id="DrugDDI.d273.s15" origId="s15" text="Drugs With A Narrow Therapeutic Index Digoxin A single dose of eszopiclone 3 mg did not affect the pharmacokinetics of digoxin measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days."><entity id="DrugDDI.d273.s15.e0" origId="s15.p166" charOffset="0-5" type="drug" text="Drugs"/><entity id="DrugDDI.d273.s15.e1" origId="s15.p168" charOffset="63-79" type="drug" text="eszopiclone 3 mg"/><entity id="DrugDDI.d273.s15.e2" origId="s15.p173" charOffset="119-126" type="drug" text="digoxin"/><pair id="DrugDDI.d273.s15.p0" e1="DrugDDI.d273.s15.e0" e2="DrugDDI.d273.s15.e1" interaction="false"/><pair id="DrugDDI.d273.s15.p1" e1="DrugDDI.d273.s15.e0" e2="DrugDDI.d273.s15.e2" interaction="false"/><pair id="DrugDDI.d273.s15.p2" e1="DrugDDI.d273.s15.e1" e2="DrugDDI.d273.s15.e2" interaction="false"/></sentence><sentence id="DrugDDI.d273.s16" origId="s16" text="Warfarin Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin"><entity id="DrugDDI.d273.s16.e0" origId="s16.p183" charOffset="0-23" type="drug" text="Warfarin Eszopiclone 3"/><entity id="DrugDDI.d273.s16.e1" origId="s16.p200" charOffset="107-115" type="drug" text="warfarin"/><entity id="DrugDDI.d273.s16.e2" origId="s16.p211" charOffset="232-240" type="drug" text="warfarin"/><pair id="DrugDDI.d273.s16.p0" e1="DrugDDI.d273.s16.e0" e2="DrugDDI.d273.s16.e1" interaction="false"/><pair id="DrugDDI.d273.s16.p1" e1="DrugDDI.d273.s16.e0" e2="DrugDDI.d273.s16.e2" interaction="false"/><pair id="DrugDDI.d273.s16.p2" e1="DrugDDI.d273.s16.e1" e2="DrugDDI.d273.s16.e2" interaction="false"/></sentence><sentence id="DrugDDI.d273.s17" origId="s17" text="."/><sentence id="DrugDDI.d273.s18" origId="s18" text="? ?"/></document>